Meininger G - Search Results

1

A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures.

Patel CA, Bailey RA, Vijapurkar U, Meininger G, Blonde L. Patel CA, et al. Among authors: meininger g. BMC Health Serv Res. 2016 Aug 5;16(a):356. doi: 10.1186/s12913-016-1607-z. BMC Health Serv Res. 2016. PMID: 27495291 Free PMC article.

2

Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus.

Wilding JP, Blonde L, Leiter LA, Cerdas S, Tong C, Yee J, Meininger G. Wilding JP, et al. Among authors: meininger g. J Diabetes Complications. 2015 Apr;29(3):438-44. doi: 10.1016/j.jdiacomp.2014.12.016. Epub 2014 Dec 31. J Diabetes Complications. 2015. PMID: 25660137 Free article. Clinical Trial.

3

Bailey RA, Vijapurkar U, Meininger G, Rupnow MF, Blonde L. Bailey RA, et al. Among authors: meininger g. Clin Ther. 2015 May 1;37(5):1045-54. doi: 10.1016/j.clinthera.2015.02.020. Epub 2015 Mar 18. Clin Ther. 2015. PMID: 25795432

4

The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus.

Gavin JR 3rd, Davies MJ, Davies M, Vijapurkar U, Alba M, Meininger G. Gavin JR 3rd, et al. Among authors: meininger g. Curr Med Res Opin. 2015;31(9):1693-702. doi: 10.1185/03007995.2015.1067192. Epub 2015 Sep 4. Curr Med Res Opin. 2015. PMID: 26121561 Clinical Trial.

5

Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.

Blonde L, Woo V, Mathieu C, Yee J, Vijapurkar U, Canovatchel W, Meininger G. Blonde L, et al. Among authors: meininger g. Curr Med Res Opin. 2015 Nov;31(11):1993-2000. doi: 10.1185/03007995.2015.1082991. Epub 2015 Sep 28. Curr Med Res Opin. 2015. PMID: 26373629

6

Renal effects of canagliflozin in type 2 diabetes mellitus.

Perkovic V, Jardine M, Vijapurkar U, Meininger G. Perkovic V, et al. Among authors: meininger g. Curr Med Res Opin. 2015 Dec;31(12):2219-31. doi: 10.1185/03007995.2015.1092128. Epub 2015 Oct 23. Curr Med Res Opin. 2015. PMID: 26494163 Review.

7

Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis.

Sinclair AJ, Bode B, Harris S, Vijapurkar U, Shaw W, Desai M, Meininger G. Sinclair AJ, et al. Among authors: meininger g. J Am Geriatr Soc. 2016 Mar;64(3):543-52. doi: 10.1111/jgs.14028. J Am Geriatr Soc. 2016. PMID: 27000327 Free PMC article. Clinical Trial.

8

Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeks.

Blonde L, Stenlöf K, Fung A, Xie J, Canovatchel W, Meininger G. Blonde L, et al. Among authors: meininger g. Postgrad Med. 2016 May;128(4):371-80. doi: 10.1080/00325481.2016.1169894. Epub 2016 Apr 7. Postgrad Med. 2016. PMID: 27002421

9

Efficacy and Safety of Canagliflozin in Type 2 Diabetes Patients of Different Ethnicity.

Davidson JA, Aguilar R, Lavalle González FJ, Trujillo A, Alba M, Vijapurkar U, Meininger G. Davidson JA, et al. Among authors: meininger g. Ethn Dis. 2016 Apr 21;26(2):221-8. doi: 10.18865/ed.26.2.221. Ethn Dis. 2016. PMID: 27103773 Free PMC article.

10

Achieving the composite endpoint of HbA1c, body weight, and systolic blood pressure reduction with canagliflozin in patients with type 2 diabetes.

Merton K, Davies MJ, Vijapurkar U, Inman D, Meininger G. Merton K, et al. Among authors: meininger g. Curr Med Res Opin. 2018 Feb;34(2):313-318. doi: 10.1080/03007995.2017.1391759. Epub 2017 Nov 16. Curr Med Res Opin. 2018. PMID: 29022746 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters